167 related articles for article (PubMed ID: 31654520)
1. Vasorelaxant Effect of Novel Nitric Oxide-Hydrogen Sulfide Donor Chalcone in Isolated Rat Aorta: Involvement of cGMP Mediated sGC and Potassium Channel Activation.
Sherikar A; Dhavale R; Bhatia M
Curr Mol Pharmacol; 2020; 13(2):126-136. PubMed ID: 31654520
[TBL] [Abstract][Full Text] [Related]
2. Vasorelaxation induced by a new naphthoquinone-oxime is mediated by NO-sGC-cGMP pathway.
Dantas BP; Ribeiro TP; Assis VL; Furtado FF; Assis KS; Alves JS; Silva TM; Camara CA; França-Silva MS; Veras RC; Medeiros IA; Alencar JL; Braga VA
Molecules; 2014 Jul; 19(7):9773-85. PubMed ID: 25006785
[TBL] [Abstract][Full Text] [Related]
3. Vasorelaxant effect of sinensetin via the NO/sGC/cGMP pathway and potassium and calcium channels.
Yam MF; Tan CS; Shibao R
Hypertens Res; 2018 Oct; 41(10):787-797. PubMed ID: 30111856
[TBL] [Abstract][Full Text] [Related]
4. Procyanidin C1 causes vasorelaxation through activation of the endothelial NO/cGMP pathway in thoracic aortic rings.
Byun EB; Sung NY; Yang MS; Song DS; Byun EH; Kim JK; Park JH; Song BS; Lee JW; Park SH; Byun MW; Kim JH
J Med Food; 2014 Jul; 17(7):742-8. PubMed ID: 24971771
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway.
Wu D; Hu Q; Ma F; Zhu YZ
Oxid Med Cell Longev; 2016; 2016():7075682. PubMed ID: 26635911
[TBL] [Abstract][Full Text] [Related]
6. Vasorelaxant effects of Shunaoxin pill are mediated by NO/cGMP pathway, HO/CO pathway and calcium channel blockade in isolated rat thoracic aorta.
Huo L; Zhang J; Qu Z; Chen H; Li Y; Gao W
J Ethnopharmacol; 2015 Sep; 173():352-60. PubMed ID: 26239154
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
[TBL] [Abstract][Full Text] [Related]
8. Vasorelaxant Action of the Chloroform Fraction of Orthosiphon stamineus via NO/cGMP Pathway, Potassium and Calcium Channels.
Yam MF; Tan CS; Ahmad M; Ruan S
Am J Chin Med; 2016; 44(7):1413-1439. PubMed ID: 27785939
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.
Hussain MB; MacAllister RJ; Hobbs AJ
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1151-9. PubMed ID: 11179059
[TBL] [Abstract][Full Text] [Related]
10. Relaxing effects of phytoestrogen alpha-zearalanol on rat thoracic aorta rings in vitro.
Wang W; Jiang D; Zhu Y; Liu W; Duan J; Dai S
Chin J Physiol; 2009 Apr; 52(2):99-105. PubMed ID: 19764345
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of vasorelaxation induced by ethanol extract of Sophora flavescens in rat aorta.
Jin SN; Wen JF; Li X; Kang DG; Lee HS; Cho KW
J Ethnopharmacol; 2011 Sep; 137(1):547-52. PubMed ID: 21704693
[TBL] [Abstract][Full Text] [Related]
12. The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat.
França-Silva MS; Luciano MN; Ribeiro TP; Silva JS; Santos AF; França KC; Nakao LS; Athayde-Filho PF; Braga VA; Medeiros IA
Eur J Pharmacol; 2012 Sep; 690(1-3):170-5. PubMed ID: 22796675
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effects of allicin on spontaneously hypertensive rats via vasorelaxation and hydrogen sulfide mechanisms.
Cui T; Liu W; Chen S; Yu C; Li Y; Zhang JY
Biomed Pharmacother; 2020 Aug; 128():110240. PubMed ID: 32480217
[TBL] [Abstract][Full Text] [Related]
14. Sulfhydration-associated phosphodiesterase 5A dimerization mediates vasorelaxant effect of hydrogen sulfide.
Sun Y; Huang Y; Yu W; Chen S; Yao Q; Zhang C; Bu D; Tang C; Du J; Jin H
Oncotarget; 2017 May; 8(19):31888-31900. PubMed ID: 28404873
[TBL] [Abstract][Full Text] [Related]
15. Vasorelaxation elicited by endogenous and exogenous hydrogen sulfide in mouse mesenteric arteries.
Hart JL
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):551-564. PubMed ID: 31713651
[TBL] [Abstract][Full Text] [Related]
16. Investigation of anti-inflammatory, nitric oxide donating, vasorelaxation and ulcerogenic activities of 1, 3-diphenylprop-2-en-1-one derivatives in animal models.
Sherikar A; Dhavale R; Bhatia M
Clin Exp Pharmacol Physiol; 2019 May; 46(5):483-495. PubMed ID: 30714176
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation.
Smimmo M; Casale V; Casillo GM; Mitidieri E; d'Emmanuele di Villa Bianca R; Bello I; Schettino A; Montanaro R; Brancaleone V; Indolfi C; Cirino G; Di Lorenzo A; Bucci M; Panza E; Vellecco V
Biomed Pharmacother; 2024 May; 174():116466. PubMed ID: 38552439
[TBL] [Abstract][Full Text] [Related]
18. Vasorelaxant action of an ethylacetate fraction of Euphorbia humifusa involves NO-cGMP pathway and potassium channels.
Wang TT; Zhou GH; Kho JH; Sun YY; Wen JF; Kang DG; Lee HS; Cho KW; Jin SN
J Ethnopharmacol; 2013 Jul; 148(2):655-63. PubMed ID: 23707330
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
[TBL] [Abstract][Full Text] [Related]
20. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet.
Hardy P; Abran D; Hou X; Lahaie I; Peri KG; Asselin P; Varma DR; Chemtob S
Circ Res; 1998 Oct; 83(7):721-9. PubMed ID: 9758642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
